Ami Bautista

• Strategic partner to identify and tackle priority projects, critical to current and future innovative opportunities across Corporate Affairs, providing insights, critical thinking, and project management skills to define actionable solutions to complex problems, such as establishing streamlined patient engagement methods, enabling 30+ patients to engage virtually in 2020, 5-fold increase from 2019.
• Translate business needs into actionable solutions, connecting innovative technologies, process improvements, and resource models to drive transformative change, such as establishing CRM database to manage 250+ advocacy partners and over 350+ sponsorships/ initiatives annually, leveraging strong analytical skills to deliver real-time insights and data-driven impact reports.
• Developed, implemented and continuously manage the financial planning and execution across Corporate Affairs - GCO, launching a centralized, streamlined, compliant budget management process and resource team, delivering real-time analytics and on-target management across $60M+ and 20+ budget owners.
• Partner with business leaders across the organization (eg, R&D, Commercial, Medical, Compliance, Finance, IS, HR, GL&P, Legal, Congress Planning, Customer 360, Work Empowered) to identify and deliver collective solutions, balancing needs of different stakeholders, such as enabling a rapid COVID-19 cross-functional donation process, or highlighting insights from external advocacy partners across the health equity rapidly evolving landscape, shaping business decisions and strategies for 2021.
• Developed 6+ channels for diverse collaboration, ways to amplify insights, share knowledge, and connect & upskill staff globally: Online Database of Best Practices, MS Teams Ways of Working & Governance, In-person forums, Newsletters / reports, LIVE Event Calendar, Advocacy Academy.
• Leverage Voice of Customer (both internal & external) interviews, reports and surveys, analyze key performance metrics for all business processes and communication channels, and monitor industry trends and business needs to predict and be proactive in developing future state team and process capabilities.
• Maintain operational excellence, enabling greater focus on patients and our partners while reducing cost and burden on Amgen staff; 5+ global processes established, supplier relationship manager for 3 key agencies and manage 15 CWs, increasing team productivity by 20%.
• Examples include: Budget Management, Administrative Support, Compliance Sponsorship Contracting, and Patient Engagement.

· Employed skills in organizational change management, strategic thinking & innovation, business relationship management, operational excellence, financial management and communication excellence to shape & establish Advocacy Relations as a function at Amgen.

· Established governance and SLT ways of working, facilitating cross-regional/ cross-functional alignment while elevating challenges to address or innovative ideas to pursue, deploying tangible deliverables, such as the Advocacy Academy, Narrative, GLRA Roles & Ways of Working & annual summit.

· Developed and implemented strategic planning annual processes across all of Advocacy Relations, relying on insights to actions. Deployed numerous tools, resources, and templates to regions and affiliates to support advocacy strategy and engagements. Drove annual global goal setting and performance metrics.

· Drove cross-regional, cross-functional internal communications, developing the Advocacy Relations narrative with senior leadership and connecting the 65+ staff Advocacy professionals across Amgen, establishing best practices and shared resources.

· Drove transformation of fragmented, mis-aligned financial management processes (~$5M), into streamlined, transparent and real-time support processes, establishing unique resource model to efficiently coordinate and enable data-driven decision making in funding and partnership levels.

· Transformed & centralized the way we engaged agency services - maximizing outputs while reducing cost and alleviating burden from the Amgen staff. Business process owner for 2 key global processes and vendor relationship manager for 6 key vendors globally, including managing 1 FTE and 2 CWs.

· Key liaison driving continued alignment, collaboration, and coordination of cross-functional initiatives across Compliance, Legal, Finance, HR, Global Learning & Performance, and targeted SLT endorsed workstreams (eg, Advocacy biosimilar strategy, General Manager Development Program – Partnerships).

• Employed skills in organizational change, communication, and relationship management to help shape the foundation of a new and evolving service-oriented organization, working as the liaison to translate business needs into IT long-term strategies and architecture.

• Business Relationship & Technology Lead managing a a portfolio of ~18 strategic cross-functional engagements (eg, HR, Accounting, Facilities, GL&P and Global Business Services), across 10+ team of talented IS professionals, leveraging program management and transformation capability skill sets to define future state, analyze solutions, define business cases and influence implementation of technology-enabled solutions to address business needs.

• Rapidly developed and deployed framework for 10 key business services, working with leadership to support change management & enterprise communication and adoption strategies while maintaining a focus on the experience of Amgen staff (the end-users), bringing alignment across services in customer SLAs, user-interface experiences, demand intake processes, and access to information.

• Drove the strategy & technology upgrades for the internal IS service portal, transforming into a dynamic, user-friendly, mobile-friendly, engaging self-service portal, leading the cultural change through enterprise communication and engagement materials, while influencing the alignment across a diverse set of processes and functions.

• Influenced methodology and adoption of Scaled Agile Framework (SAFe) software development at Amgen, standing up the first Agile Release Train (team of teams all working together to build simultaneous efforts on a single platform). Demonstrated 50% increase in productivity within first 6 months, guiding 20+ resources (internal, external, cross-functional) to delivery key efficient, scalable, and customer focused business outcomes.

• Recruited by Amgen’s internal corporate strategy team to work on a set of CEO-sponsored initiatives aimed at re-positioning an R&D organization of 4,000+ employees with an annual spend of $4.1B; Appointed as the portfolio manager across 10+ cross-functional, transformational workstreams focused on organizational, process, and geographical transformations; developed and owned a new technology solution to manage the broad scale capacity of the portfolio while ensuring adherence to CEO timeline expectations, leading the change management and communication strategy, and responsible for monthly updates to the EVP of R&D and senior leadership team.

• Managed a diverse, cross-functional senior leadership team of 15 in reshaping Amgen’s discovery commercialization process across a 2,000-person organization, designing the change management steps & working through complexity, ambiguity, and multiple viewpoints, to build a future state model that will shorten programmatic critical path and drive productivity. Accomplished in a near net budget neutral environment. Developed all communication and presentation materials, gaining CEO approval for business case and solution design, leading to dramatic decrease in time between discovery and product launch, accelerating life-saving medicines into the hands of patients.

• Managed a team of 27 R&D, IT, and corporate strategy leaders in establishing the design of a 5 year investment portfolio (~$62M) in R&D Knowledge Management opportunities across 9 dimensions and 19 discrete projects, ensuring value of the investment will be achieved to accelerate and transform internal drug discovery. Gained CEO approval for long-term technology investment strategy.

• Successfully led transformation efforts across the business through workshop facilitation, influencing the design of strategic solutions integrating technology, efficient processes, and behaviors. Honed skills in business case development, risk analysis, solution delivery & implementation planning, change management, communication and process re-design. Achieved “Advanced Practitioner” status within Amgen’s internal consulting team - Results Delivery Office.

• Championed operational efficiency (OE) efforts, leveraging Six Sigma methodologies, building a cross-functional OE network, establishing new best practices and change management methodologies across a ~1000 person scientific organization.

• Designed and developed a cross-functional recognition and communication program to bring attention to ongoing scientific innovation and advancements, integrating technology with cultural elements to drive collaboration and cross-pollination of ideas. Frontline staff shared over 40 high impact, productivity driven projects and innovative ideas within first 6 months.

• Received three scientific track promotions during 9 year tenure.

• Transformed the business strategy for supporting pre-clinical immunogenicity by leveraging a novel analytical platform, driving fit-for-purpose processes and IT systems, reducing assay readiness from ~6 months to ~2 weeks, driving increased compliance and efficiency from benchtop to final study report, including: novel immunoassay method, regulatory filing documents, validation package, reagent maintenance, automation tools, system integration, and study report templates and communication. Recognized by senior leadership internally and across external industry. First author on 3 published research articles.

• Key scientific lead for early research immunogenicity support, interpreting data, generating reports, contributing to early product teams and impact analysis while managing the resourcing, reporting, and interpretation of all early research assay support (~5 programs year/ 15 studies), performed across a team of 7 analysts across 3 departments.

• Led the establishment of scientific research assigned to multiple contract research organizations (CROs) across the US (e.g., PPD, Millipore, Covance), designing statistically based assay transfer protocols, defining scope, resource allocation, and competitive pricing, and managing vendor relations, communication, and issue resolution. All clinical immunogenicity results returned on time and on budget with 9 successful statistically based assay transfers achieved over a 5 year tenure. Recognized internally as recipient of the Medical Sciences Excellence in Science Award (2009).

• Led and managed high performing cross-functional teams from conceptualization through implementation focused on scientific innovation and operational effectiveness across diverse subject matter expertise (e.g., research, automation, information systems, and statistics). Recognized internally as recipient of the Medical Sciences Excellence in Science Award- Scientific Advancement (2010).

• Managed strategy & execution of internal scientific conference, ensuring scientific integrity and high impact factor for all presentations and workshop seminars, maintaining project timeline, and efficiently organizing/ coordinating all activities, poster session details, and internal/ external schedules. Highly successful event attended by 5 R&D departments and over 200 attendees across 3 Amgen sites.

· Quickly learned new skills and applied them to daily tasks, improving efficiency and productivity while managing several complex projects, beyond job scope, to continue to grow and learn while providing value to the business.

· Demonstrated respect, friendliness and willingness to help wherever needed.

• In depth knowledge of immunoassays, bioassays, and multiple assay platforms (ie, ELISA, Meso Scale Discovery, Biacore, DELFIA, Luminex, Starlims, and Envision)